PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy

Exclusion Criteria

• •1. Decompensated heart failure within 48 hours prior to enrollment.
• •2. Recent ST-segment elevation myocardial infarction (STEMI) within less than 4 weeks.
• •3. Left ventricular aneurysm.
• •4. Judged by the investigator as unable to complete PET examination.
• •5. Severe renal insufficiency.
• •6. Severe hepatic insufficiency.
• •7. Subjects with fever or active infectious diseases who are assessed by the investigator as unsuitable for study participation.
• •8. Pregnant or lactating women.
• •9. Contraindications to magnetic resonance imaging (MRI), such as claustrophobia or intracorporeal metallic implants.
• •10. Subjects with mental disorders or poor compliance.
• •11. Significant occupational exposure to ionizing radiation (e.g., exceeding 50 mSv per year) or exposure to radioactive substances/ionizing radiation for therapeutic or research purposes within the past 10 years.
• •12. Other circumstances deemed by the investigator as unsuitable for trial participation.